Zhao Z - Search Results

1

Label-free detection of Alzheimer's disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide.

Zhao Z, Zhu L, Bu X, Ma H, Yang S, Yang Y, Hu Z. Zhao Z, et al. Chem Commun (Camb). 2015 Jan 14;51(4):718-21. doi: 10.1039/c4cc07037b. Chem Commun (Camb). 2015. PMID: 25418132

2

Antibody-Mimetic Peptoid Nanosheet for Label-Free Serum-Based Diagnosis of Alzheimer's Disease.

Zhu L, Zhao Z, Cheng P, He Z, Cheng Z, Peng J, Wang H, Wang C, Yang Y, Hu Z. Zhu L, et al. Among authors: zhao z. Adv Mater. 2017 Aug;29(30). doi: 10.1002/adma.201700057. Epub 2017 Jun 12. Adv Mater. 2017. PMID: 28605073

3

Detection of Parkinson's Disease through the Peptoid Recognizing α-Synuclein in Serum.

Gao H, Zhao Z, He Z, Wang H, Liu M, Hu Z, Cheng O, Yang Y, Zhu L. Gao H, et al. Among authors: zhao z. ACS Chem Neurosci. 2019 Mar 20;10(3):1204-1208. doi: 10.1021/acschemneuro.8b00540. Epub 2019 Jan 29. ACS Chem Neurosci. 2019. PMID: 30682886

4

Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by the Plasma and Serum Amyloid-beta 42 Assay through Highly Sensitive Peptoid Nanosheet Sensor.

Gao H, Liu M, Zhao Z, Yang C, Zhu L, Cai Y, Yang Y, Hu Z. Gao H, et al. Among authors: zhao z. ACS Appl Mater Interfaces. 2020 Feb 26;12(8):9693-9700. doi: 10.1021/acsami.0c00370. Epub 2020 Feb 12. ACS Appl Mater Interfaces. 2020. PMID: 32013375

5

Antiamyloidogenic Activity of Aβ42-Binding Peptoid in Modulating Amyloid Oligomerization.

Zhao Z, Zhu L, Li H, Cheng P, Peng J, Yin Y, Yang Y, Wang C, Hu Z, Yang Y. Zhao Z, et al. Small. 2017 Jan;13(1). doi: 10.1002/smll.201602857. Epub 2016 Oct 7. Small. 2017. PMID: 27714968

6

Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles.

Li W, Wang H, Zhao Z, Gao H, Liu C, Zhu L, Wang C, Yang Y. Li W, et al. Among authors: zhao z. Adv Mater. 2019 Nov;31(45):e1805344. doi: 10.1002/adma.201805344. Epub 2018 Dec 27. Adv Mater. 2019. PMID: 30589111 Review.

7

Enhanced blood-brain-barrier penetrability and tumor-targeting efficiency by peptide-functionalized poly(amidoamine) dendrimer for the therapy of gliomas.

Liu C, Zhao Z, Gao H, Rostami I, You Q, Jia X, Wang C, Zhu L, Yang Y. Liu C, et al. Among authors: zhao z. Nanotheranostics. 2019 Sep 19;3(4):311-330. doi: 10.7150/ntno.38954. eCollection 2019. Nanotheranostics. 2019. PMID: 31687320 Free PMC article.

8

Improving the inhibitory effect of CXCR4 peptide antagonist in tumor metastasis with an acetylated PAMAM dendrimer.

Liu C, Duan H, Zhao Z, Li W, Ma L, Fang X, Wang C, Yang Y. Liu C, et al. Among authors: zhao z. RSC Adv. 2018 Nov 30;8(70):39948-39956. doi: 10.1039/c8ra08526a. eCollection 2018 Nov 28. RSC Adv. 2018. PMID: 35558209 Free PMC article.

9

Correction: Improving the inhibitory effect of CXCR4 peptide antagonist in tumor metastasis with an acetylated PAMAM dendrimer.

Liu C, Duan H, Zhao Z, Li W, Ma L, Fang X, Wang C, Yang Y. Liu C, et al. Among authors: zhao z. RSC Adv. 2018 Dec 18;8(73):42253. doi: 10.1039/c8ra90102c. eCollection 2018 Dec 12. RSC Adv. 2018. PMID: 35560735 Free PMC article.

10

Correction: Improving the inhibitory effect of CXCR4 peptide antagonist in tumor metastasis with an acetylated PAMAM dendrimer.

Liu C, Duan H, Zhao Z, Li W, Ma L, Fang X, Wang C, Yang Y. Liu C, et al. Among authors: zhao z. RSC Adv. 2019 May 29;9(29):16729. doi: 10.1039/c9ra90039j. eCollection 2019 May 24. RSC Adv. 2019. PMID: 35532498 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31,975 results

Search Page

Filters